Kornitzer Capital Management’s West Pharmaceutical WST Stock Holding History

Kornitzer Capital Management’s Portfolio WST Stock Details WST Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$4.91M	Hold	13,668	–	–	0.1%	194
2026 Q1	$3.43M	Buy	+13,668	New	+$3.4M	0.07%	236
2025 Q3	–	Sell	-21,185	Closed	-$4.64M	–	533
2025 Q2	$4.64M	Hold	21,185	–	–	0.09%	243
2025 Q1	$4.74M	Sell	21,185 -147	-0.7%	-$40.5K	0.1%	233
2024 Q4	$6.99M	Sell	21,332 -2	-0%	-$629	0.14%	207
2024 Q3	$6.4M	Buy	21,334 +334	+2%	+$102K	0.12%	228
2024 Q2	$6.92M	Buy	+21,000	New	+$7.42M	0.13%	213
2019 Q1	–	Sell	-223,625	Closed	-$21.9M	–	496
2018 Q4	$21.9M	Buy	223,625 +1,610	+0.7%	+$175K	0.44%	82
2018 Q3	$27.4M	Buy	+222,015	New	+$24.9M	0.44%	83

Other funds holding WST

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

GIM

Generation Investment Management London, United Kingdom $10.3B AUM 4.84% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

Kornitzer Capital Management's WST Position: Q2 2026 in Review

Kornitzer Capital Management held its West Pharmaceutical (WST) position steady in Q2 2026 at 13,668 shares worth $4.91M. The position accounts for 0.1% of the portfolio, ranked #194.

Kornitzer Capital Management first reported a position in WST in Q3 2018 and has held it in 9 quarters since. The position peaked at $27.4M in Q3 2018. 831 funds tracked by Wall St. Rank hold WST as of Q2 2026.

Kornitzer Capital Management held 13,668 shares of West Pharmaceutical worth $4.91M as of Q2 2026.
Kornitzer Capital Management left its West Pharmaceutical share count unchanged in Q2 2026.
West Pharmaceutical made up 0.1% of Kornitzer Capital Management's portfolio in Q2 2026, its #194 holding.
Kornitzer Capital Management first reported a position in West Pharmaceutical in Q3 2018 and has held it in 9 quarters since.
Kornitzer Capital Management's West Pharmaceutical position peaked at $27.4M in Q3 2018.
831 funds tracked by Wall St. Rank held West Pharmaceutical as of Q2 2026.

Based on Kornitzer Capital Management's 13F filing for Q2 2026, filed 31 Jul 2026.